Clal Biotechnology Industries (XTAE:CBI) 3-Year EBITDA Growth Rate : 86.70% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries 3-Year EBITDA Growth Rate?

Clal Biotechnology Industries's EBITDA per Share for the three months ended in Dec. 2023 was ₪0.00.

During the past 12 months, Clal Biotechnology Industries's average EBITDA Per Share Growth Rate was 30.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 86.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Clal Biotechnology Industries was 160.50% per year. The lowest was -265.90% per year. And the median was -16.00% per year.

Competitive Comparison of Clal Biotechnology Industries's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Clal Biotechnology Industries's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clal Biotechnology Industries's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clal Biotechnology Industries's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Clal Biotechnology Industries's 3-Year EBITDA Growth Rate falls into.

Clal Biotechnology Industries 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Clal Biotechnology Industries (XTAE:CBI) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Clal Biotechnology Industries 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Clal Biotechnology Industries (XTAE:CBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.